- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
No Wall Street Crash for Biotech
When Warren Buffet was ten, he made his first trip to NYC. What did he want to do? “See the Stock Exchange,” he told a news reporter on TV yesterday.
When Warren Buffet was ten, he made his first trip to NYC. What did he want to do? “See the Stock Exchange,” he told a news reporter on TV yesterday. “It is the epicenter of Capitalization.” Buffet claims he feels exactly the same excitement today as he did then as a ten year old whenever he visits the Floor. He was in NYC to promote his son Peter’s book, “Life is What You Make It.”
This month, of course, marks the anniversary of The Wall Street Crash of 1929, the most devastating stock market crash in the history of the United States. The crash signaled the beginning of the 10-year Great Depression that affected all Western industrialized countries. We’re holding our breath, but so far it looks like clear sailing with no October surprises in store, especially for biotech.
As of yesterday, the 10 Best Biotech Stocks for 2013 were looking like this. (Source: TheStreet Ratings
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
